Video Library

Transcript of Presentation: (00:00:01): [Jordan Sexton]: Introduction. Good morning and good afternoon. Welcome to the workshop, Men's Sexual Health after Transplant. My name is Jordan Sexton and I will be

Tryout three mindfulness mediation exercises to relieve stress, help manage pain and improve quality of life.

After being diagnosed with myelodysplastic syndrome, nurse Justin Regan underwent two stem cell transplants using cells from a donor. He recounts his experience and shares what inspired him to continue on through treatment, despite the difficulties.

Long-term health consequences of stem cell transplant using donor cells (an allogeneic transplant) are very real, although they affect a minority of patients and can often be treated effectively. This presentation reviews the most common problems following an allogeneic transplant and the therapies available to treat them.

Resumen: El trasplante con células de un donante (trasplante alogénico) puede causar efectos tardíos en la salud meses o años después del trasplante. Este video describe posibles complicaciones tardías o a largo plazo después del trasplante, cómo reducir el riesgo de desarrollar complicaciones y opciones de tratamiento.

Autologous stem cell transplants are a treatment option primarily for patients with multiple myeloma and non-Hodgkin lymphoma. High-dose chemotherapy is part of the treatment and can destroy cancer cells as well as healthy blood cells. Although side effects do occur after an autologous stem cell transplant, most patients can expect a return to normal, healthy life after transplant.

Descargue las Diapositivas de la Presentación Proteja su Salud después de un Trasplante Utilizando sus Propias Células (Trasplante Autólogo) (Protect Your Health after a Transplant Using Your Own Cells -

CAR-T cell therapy is a promising new treatment for multiple myeloma. This presentation describes the versions of this therapy that are currently available, their potential complications and side effects, and the risk/benefit calculations in deciding when this treatment is appropriate.

This video will discuss why a patient with acute lymphoblastic leukemia (ALL) may need CAR T-cell therapy; the steps involved in making a CAR T-cell product; how CAR T-cells are administered to patients; and both short- and long-term side effects, and outcomes associated with CAR T-cell the

CAR T-cell therapy is a new treatment option for lymphoma patients whose disease has been resistant to standard chemotherapy. This presentation describes what’s involved in going through CAR T-cell therapy, the CAR T-cell products currently approved by the FDA, and the short- and long-term side effects of treatment.

Descargue las Diapositivas de la Presentación ¿Qué es la Terapia de Células CAR-T? (What is CAR T-cell Therapy?) Miércoles 3 de mayo de 2023 Presentador: Miguel-Angel Perales, MD, Memorial Sloan

Download Speaker Slides Transplant and CAR T-cell Therapy in Older Adults Sunday, April 30, 2023 Presenter: Richard Lin MD, PhD, Memorial Sloan Kettering Cancer Center Presentation is 35 minutes long